Cargando…
Synergistic Antitumor Activity of SH003 and Docetaxel via EGFR Signaling Inhibition in Non-Small Cell Lung Cancer
Epidermal growth factor receptor (EGFR) is overexpressed in lung cancer patients. Despite treatment with various EGFR tyrosine kinase inhibitors, recurrence and metastasis of lung cancer are inevitable. Docetaxel (DTX) is an effective conventional drug that is used to treat various cancers. Several...
Autores principales: | Jeong, Mi-So, Lee, Kang-Wook, Choi, Yu-Jeong, Kim, Yun-Gyeong, Hwang, Hyun-Ha, Lee, Seo-Yeon, Jung, Se-Eun, Park, Sun-Ah, Lee, Jin-Hee, Joo, Yong-Joon, Cho, Sung-Gook, Ko, Seong-Gyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8395077/ https://www.ncbi.nlm.nih.gov/pubmed/34445110 http://dx.doi.org/10.3390/ijms22168405 |
Ejemplares similares
-
SH003 and Docetaxel Show Synergistic Anticancer Effects by Inhibiting EGFR Activation in Triple-Negative Breast Cancer
por: Choi, Yu-Jeong, et al.
Publicado: (2022) -
Herbal Prescription SH003 Alleviates Docetaxel-Induced Neuropathic Pain in C57BL/6 Mice
por: Lee, Kangwook, et al.
Publicado: (2021) -
Metabolomic Analysis of Exosomes Derived from Lung Cancer Cell Line H460 Treated with SH003 and Docetaxel
por: Choi, Yu-Jeong, et al.
Publicado: (2022) -
SH003 induces apoptosis of DU145 prostate cancer cells by inhibiting ERK-involved pathway
por: Choi, Yu-Jeong, et al.
Publicado: (2016) -
SH003 suppresses breast cancer growth by accumulating p62 in autolysosomes
por: Choi, Youn Kyung, et al.
Publicado: (2016)